Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTE + L-T4 for TSH Suppression in Differentiated Thyroid Cancer (DELTA)
NCT07239674Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of thyroid, porcine in differentiated thyroid cancer (DTC), sponsored by West China Hospital of Sichuan University. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
thyroid, porcine
03
Conditions
differentiated thyroid cancer (DTC)
Beyond the preview
Go deeper on NCT07239674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07239674.